FDA Adverse Event Other Summary report: N

SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE

MDR report key: 2213996 · Received June 23, 2011

Report

Report Number
1220423-2011-00019
Event Type
Other
Date Received
June 23, 2011
Report Date
June 16, 2011
Manufacturer
GENZYME BIOSURGERY (SEPRAFILM/PACK)
Product Code
MCN
PMA / PMN Number
P950034
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SEE MFR'S CONTROL NUMBER (B)(4) FOR OTHER ADVERSE EVENTS FROM THIS REPORTER. MFR'S COMMENT: THE BENEFIT-RISK RELATIONSHIP OF SEPRAFILM IS NOT AFFECTED BY THIS REPORT.

Description of Event or Problem · 1

BOWEL OBSTRUCTION [INTESTINAL OBSTRUCTION]. PERITONEAL PERITONITIS [PERITONITIS]. CASE DESCRIPTION: SPONTANEOUS REPORT WAS RECEIVED ON (B)(4) 2011, FROM A PHYSICIAN VIA A COMPANY SALES REPRESENTATIVE REGARDING A PT, INITIALS NOT PROVIDED. THE PT'S MEDICAL HISTORY WAS NOT PROVIDED. ON AN UNSPECIFIED DATE, THE PT HAD AN UNSPECIFIED SURGERY DURING WHICH SEPRAFILM, LOT NUMBER UNKNOWN, WAS APPLIED. ON AN UNKNOWN DATE, THE PT HAD A SURGICAL REOPERATION FOR BOWEL OBSTRUCTION AND PERITONEAL PERITONITIS. LOCATION OF EVENT, PAST SURGICAL HISTORY, ALLERGIES, AND EXPOSURE DURING SURGERY WERE ALL UNKNOWN. THE ACTION TAKEN WITH SEPRAFILM WAS NOT PROVIDED. THE PT'S OUTCOME FOR THE EVENT WAS NOT PROVIDED. CONCOMITANT MEDICATIONS WERE NOT PROVIDED. THE REPORTING PHYSICIAN ASSESSED THE RELATIONSHIP BETWEEN SEPRAFILM AND THE EVENTS OF BOWEL OBSTRUCTION AND PERITONEAL PERITONITIS AS DEFINITELY RELATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE BIORESORBABLE ADHESION BARRIER MCN GENZYME BIOSURGERY (SEPRAFILM/PACK) UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention